Search company, investor...

Etiologics

etiologics.com

Founded Year

2002

Stage

Merger | Acquired

Total Raised

$5.37M

About Etiologics

Developer of therapies for chronic respiratory disease. The company's therapeutic interests are in chronic obstructive pulmonary disease (COPD), cystic fibrosis and severe asthma. In November 2002 the company acquired the core respiratory pre-clinical research group from the international pharmaceutical company Bayer. This acquisition also brought a number of assets including some disease models of COPD as well as proprietary automated screening and imaging technologies for following the progression of COPD in these models. The company has built a flexible drug discovery pipeline and aims to apply this knowledge to drive both its own internal drug discovery programme and to partnering this expertise with pharma. A central component to the company's drug discovery pipeline is the development, refinement and exploitation of in vivo models of human disease.

Headquarters Location

Stoke Court

Slough, SL2 4LY,

United Kingdom

44 1753 649 400

Missing: Etiologics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Etiologics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Etiologics Frequently Asked Questions (FAQ)

  • When was Etiologics founded?

    Etiologics was founded in 2002.

  • Where is Etiologics's headquarters?

    Etiologics's headquarters is located at Stoke Court, Slough.

  • What is Etiologics's latest funding round?

    Etiologics's latest funding round is Merger.

  • How much did Etiologics raise?

    Etiologics raised a total of $5.37M.

  • Who are the investors of Etiologics?

    Investors of Etiologics include Argenta Discovery and AAC Capital Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.